Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode, MD, Steven Goldstein, MD, Daniel R. Couriel, MD, Thomas Braun, PhD, John M. Magenau, MD, Mary Mansour Riwes, DO, Brian Parkin, Vedran Radojcic, MD, David Frame, PharmD, Sung Choi, MD, James Connelly, MD, John E. Levine, MD MS, Gregory A. Yanik, MD, Pavan Reddy, MD

Blood (2015) 126 (23): 1907.

https://doi.org/10.1182/blood.V126.23.1907.1907

Published: 2015

Journal Articles

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Corey Cutler, Brent Logan, Ryotaro Nakamura, Laura Johnston, Sung Choi, David Porter, William J. Hogan, Marcelo Pasquini, Margaret L. MacMillan, Jack W. Hsu, Edmund K. Waller, Stephan Grupp, Philip McCarthy, Juan Wu, Zhen-Huan Hu, Shelly L. Carter, Mary M. Horowitz, Joseph H. Antin

Blood (2014) 124 (8): 1372–1377.

https://doi.org/10.1182/blood-2014-04-567164

Published: 2014

Journal Articles

Host-derived CD8 + dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation

Tomomi Toubai, Yaping Sun, Gary Luker, Jun Liu, Kathryn E. Luker, Isao Tawara, Rebecca Evers, Chen Liu, Nathan Mathewson, Chelsea Malter, Evelyn Nieves, Sung Choi, Kenneth M. Murphy, Pavan Reddy

Blood (2013) 121 (20): 4231–4241.

https://doi.org/10.1182/blood-2012-05-432872

Published: 2013

Includes: Supplemental data

Journal Articles

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

Gregory A. Yanik, John M. Magenau, Shin Mineishi, Attaphol Pawarode, Keith Alangaden, Edward M. Peres, Steven Goldstein, John E. Levine, Sung Choi, Carrie L Kitko, Moshe Talpaz, MD, Daniel Couriel

Blood (2012) 120 (21): 3119.

https://doi.org/10.1182/blood.V120.21.3119.3119

Published: 2012

Journal Articles

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

Blood (2011) 118 (15): 4258–4264.

https://doi.org/10.1182/blood-2011-06-358010

Published: 2011

Includes: Supplemental data

Journal Articles

Follicular dendritic cell–dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion–mediated Bim down-regulation through induction of microRNA-181a

Tint Lwin, Jianhong Lin, Yong Sung Choi, Xinwei Zhang, Lynn C. Moscinski, Kenneth L. Wright, Eduardo M. Sotomayor, William S. Dalton, Jianguo Tao

Blood (2010) 116 (24): 5228–5236.

https://doi.org/10.1182/blood-2010-03-275925

Published: 2010

Includes: Supplemental data

Journal Articles

Microenvironment-Mediated Bim Down-Regulation through Induction of Microrna-181a Protects Cells From Apoptosis In Mantle-Cell and Other Non-Hodgkin B-Cell Lymphomas

Tint Lwin, MD, PhD, Jian-Hong Lin, MD, Yong Sung Choi, MD, PhD, Xinwei Zhang, MD, Lynn Moscinski, MD, Kenneth Wright, PhD, Eduardo M. Sotomayor, MD, William Dalton, PhD, MD, Jianguo Tao, MD, PhD

Blood (2010) 116 (21): 3118.

https://doi.org/10.1182/blood.V116.21.3118.3118

Published: 2010

Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Blood (2010) 116 (21): 675.

https://doi.org/10.1182/blood.V116.21.675.675

Published: 2010

Journal Articles

Microenvironment-Mediated Regulation of Micrornas In B-Lymphocytes as a Novel Mechanism for Terminal B-Cell Differentiation and Lymphomagenesis.

Jianhong Lin, M.D, Tint Lwin, MD, PhD, Wayne Tam, MD, PhD, Jian-Jun Zhao, Luis Crespo, Yong Sung Choi, Xinwei Zhang, Victoria Tannenbaum, Eduardo M. Sotomayor, MD, Lynn C. Moscinski, MD, William S. Dalton, PhD, MD, Ken Wright, PhD, Jianguo Tao, MD, PhD

Blood (2010) 116 (21): 3853.

https://doi.org/10.1182/blood.V116.21.3853.3853

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML

Shin Mineishi, MD, John Magenau, MD, Hiromi Tobai, MD, Attaphol Pawarode, MD, Edward M. Peres, MD, Pavan Reddy, MD, Carrie Kitko, MD, Sung Choi, MD, Harry P Erba, MD, PhD, Lisa Kujawski, MD, Gregory Yanik, MD, James Ferrara, MD, John E. Levine, MD, MS

Blood (2010) 116 (21): 35.

https://doi.org/10.1182/blood.V116.21.35.35

Published: 2010

Journal Articles

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Blood (2009) 114 (22): 43.

https://doi.org/10.1182/blood.V114.22.43.43

Published: 2009

Journal Articles

Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation: Incidence and Outcomes.

Yasser Khaled, MD, Sung Choi, MD, David A Hanauer, MD, MS, Pavan Reddy, MD

Blood (2009) 114 (22): 3324.

https://doi.org/10.1182/blood.V114.22.3324.3324

Published: 2009

Journal Articles

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Corey Cutler, Kristen Stevenson, Haesook T. Kim, Paul Richardson, Vincent T. Ho, Erica Linden, Carolyn Revta, Ruth Ebert, Diane Warren, Sung Choi, John Koreth, Philippe Armand, Edwin Alyea, Shelly Carter, Mary Horowitz, Joseph H. Antin, Robert Soiffer

Blood (2008) 112 (12): 4425–4431.

https://doi.org/10.1182/blood-2008-07-169342

Published: 2008

Journal Articles

Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.

Shin Mineishi, MD, John Magenau, MD, Attaphol Pawarode, MD, Timothy Buck, Dawn Jones, RN, Koji Kato, MD, David Frame, Pharm.D, Lisa Kujawski, MD, Harry Paul Erba, MD, PhD, Yasser Khaled, MD, Edward M. Peres, MD, Oleg I. Krijanovski, PhD, MD, Pavan Reddy, MD, Carrie Kitko, MD, Sung Choi, MD, Gregory A. Yanik, MD, Thomas Braun, PhD, James L.M. Ferrara, MD, John E. Levine, MD

Blood (2008) 112 (11): 2150.

https://doi.org/10.1182/blood.V112.11.2150.2150

Published: 2008

Journal Articles

Elafin Is a Biomarker of Graft Versus Host Disease of the Skin

Sophie Paczesny, MD, PhD., John E. Levine, MD, Jason Hogan, PhD., Jeffrey Crawford, Thomas Braun, PhD, Hong Wang, PhD., Vitor Faca, PhD, Qing Zhang, Sharon Pitteri, PHD, Alice Chin, Sung Choi, MD, Carrie Kitko, MD, Oleg I. Krijanovski, PhD, MD, Pavan Reddy, MD, Shin Mineishi, MD, Joel Whitfield, Dawn Jones, RN, Samir Hanash, MD, PhD, James L.M. Ferrara, MD

Blood (2008) 112 (11): 716.

https://doi.org/10.1182/blood.V112.11.716.716

Published: 2008

Journal Articles

A Four Protein Plasma Fingerprint of Acute Graft Versus Host Disease (GVHD) Predicts Long Term Survival.

Sophie Paczesny, MD, Sung Choi, MD, Thomas Braun, PhD, Carrie Kitko, MD, Krijanovski Oleg, MD, Shawn G. Clouthier, Angela Weyand, Dan Bickley, Dawn Jones, RN, Joel Whitfield, John E. Levine, MD, James L. Ferrara, MD

Blood (2007) 110 (11): 38.

https://doi.org/10.1182/blood.V110.11.38.38

Published: 2007

Journal Articles

Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation

Gerhard C. Hildebrandt, Krystyna M. Olkiewicz, Sung Choi, Leigh A. Corrion, Shawn G. Clouthier, Chen Liu, Jonathan S. Serody, Kenneth R. Cooke

Blood (2005) 105 (6): 2249–2257.

https://doi.org/10.1182/blood-2004-08-3320

Published: 2005

Journal Articles

CCR1 Expression on Donor Leukocytes Is Critical to the Development of Graft Versus Host Disease after Allogeneic SCT.

Gerhard C. Hildebrandt, MD, Sung Choi, MD, Krystyna M. Olkiewicz, MS, Stephen W. Chensue, MD, Chen Liu, MD, Kenneth R. Cooke, MD

Blood (2004) 104 (11): 3067.

https://doi.org/10.1182/blood.V104.11.3067.3067

Published: 2004

Journal Articles

IL-13 - Predictor of or Protector from Acute Graft Versus Host Disease?.

Gerhard C. Hildebrandt, MD, Krystyna M. Olkiewicz, MS, Sung Choi, MD, Leigh A. Corrion, BS, Chen Liu, MD, Andrew N. McKenzie, MD, Kenneth R. Cooke, MD

Blood (2004) 104 (11): 3070.

https://doi.org/10.1182/blood.V104.11.3070.3070

Published: 2004

Journal Articles

The Use of Laparoscopic Liver Biopsies in Pediatric Patients with Hepatic Dysfunction Following Allogeneic Hematopoietic Stem Cell Transplantation.

Sung Choi, M.D., Saleem Islam, M.D., Gregory Yanik, M.D., John E. Levine, M.D., Raymond J. Hutchinson, M.D., James L.M. Ferrara, M.D., Joel K. Greenson, M.D., Kenneth R. Cooke, M.D.

Blood (2004) 104 (11): 1147.

https://doi.org/10.1182/blood.V104.11.1147.1147

Published: 2004

NARROW

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Host-derived CD8 + dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

Follicular dendritic cell–dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion–mediated Bim down-regulation through induction of microRNA-181a

Microenvironment-Mediated Bim Down-Regulation through Induction of Microrna-181a Protects Cells From Apoptosis In Mantle-Cell and Other Non-Hodgkin B-Cell Lymphomas

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Microenvironment-Mediated Regulation of Micrornas In B-Lymphocytes as a Novel Mechanism for Terminal B-Cell Differentiation and Lymphomagenesis.

Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation: Incidence and Outcomes.

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.

Elafin Is a Biomarker of Graft Versus Host Disease of the Skin

A Four Protein Plasma Fingerprint of Acute Graft Versus Host Disease (GVHD) Predicts Long Term Survival.

Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation

CCR1 Expression on Donor Leukocytes Is Critical to the Development of Graft Versus Host Disease after Allogeneic SCT.

IL-13 - Predictor of or Protector from Acute Graft Versus Host Disease?.

The Use of Laparoscopic Liver Biopsies in Pediatric Patients with Hepatic Dysfunction Following Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only